What Usually Comes After A New High In Johnson & Johnson Stock?
For questions about this article or underlying research, email help@trefis.com.
Investors learn early to buy low and never at the top. Johnson & Johnson (JNJ) stock closed at a 52-week high on November 9, 2026, making any purchase today look too late by that standard. Does the rule hold for this stock?
Why Johnson & Johnson Stock Is At A High
The high does not come from rising profit: Johnson & Johnson earns less than it did a year ago, so investors now pay far more for each dollar of its profit. Over the past year the share price rose 50.9%, before dividends, while net income for the twelve months to September 2026 fell 35.9%. So the price-to-earnings multiple, what investors pay for each dollar of profit, went from 17.9 a year ago to 42.2 now.
One quarter accounted for much of that profit decline. Management said fiscal Q3 2026 results carried about $7 billion of costs for the proposed talc litigation resolution and two deals. Sales continued growing underneath. Innovative Medicine, the segment selling the company’s medicines, posted 7.9% sales growth in that quarter, and the immunology drug Tremfya grew 68%.
What Happened After Johnson & Johnson Stock’s Earlier Highs?
Asking what happened to people who bought at Johnson & Johnson’s earlier highs offers a more useful perspective than questioning whether the current price is too high. Seven of the nine highs since November 2016 followed by a full year of trading left the stock higher a year later. Here is how each one turned out:
| 52-week high | Stock a year later | S&P 500, same year | Lowest point in that year |
|---|---|---|---|
| Mar 2017 | +6.2% | +17.8% | -3.6% |
| Oct 2017 | -2.1% | +6.8% | -12.6% |
| Dec 2019 | +6.3% | +15.7% | -23.5% |
| Dec 2020 | +10.4% | +28.0% | -1.9% |
| Jul 2021 | +0.39% | -10.1% | -9.2% |
| Mar 2022 | -13.7% | -10.7% | -15.9% |
| Aug 2024 | +7.8% | +15.1% | -14.3% |
| Mar 2025 | +44.9% | +20.7% | -12.7% |
| Sep 2025 | +48.9% | +15.5% | 0.0% |
A 52-week high is a close above every close of the 252 trading sessions before it, counted no more than once every 126 trading sessions. A year later is the close 252 trading sessions after the high. Changes are measured from the close on the day of the high; 0.0% in the last column means the stock did not close below it. Split-adjusted closing prices, dividends excluded.
The middle result was a gain of 6.3% a year later. The stock outperformed the S&P 500 after only three of the highs. Even so, buying Johnson & Johnson at a high usually has not been a mistake.
Is A High A Worse Time To Buy?
No, not for Johnson & Johnson. The stock was typically up 4.9% a year after being bought on any trading day from November 2016 to November 2025, slightly less than its performance following a high. So the old rule did not hold for this stock: a high has been no worse a time to buy it than an ordinary day, and slightly better.
What Should A Buyer At A High Expect?
The rule is not foolish, as the worst of the earlier highs demonstrates. A buyer at the March 2022 high was down 13.7% a year later, in March 2023. That was the worst of the nine, however, and buyers at most of the other highs experienced a dip along the way before ending the year higher.
Anyone buying at a high should prepare for a dip. In the typical year following one, Johnson & Johnson stock’s lowest close was 12.6% below the price paid.
What Would Selling Your Johnson & Johnson Shares Cost In Tax?
Shares from grants or a purchase plan, held for years, can carry a large taxable gain. A free 30-minute strategy review with our partner advisory firm covers a lower-tax way to sell them down and protect the rest.
Spot an error or want more like this? Tell us in 10 seconds.